ARNA Discussion Board - Credit Suisse -Atopic Derm Data in Q4 is the Next Key Catalyst - ARNA Discussion Board - InvestorVillage
ARNA Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: ARNA Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  56187 of 57431  at  8/6/2020 12:01:46 AM  by

crescentmotor


 In response to msg 56181 by  Cyclist
view thread

Re: Credit Suisse -Atopic Derm Data in Q4 is the Next Key Catalyst

"...AD readout, with market comps suggesting upside of as much as ~$25-40+/sh is possible on convincing Ph2 results..."
 
Wonder what numbers will eventually be floated with regard to potential upside in the Olorinab  Ph2b trial?


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 115
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...